{"nctId":"NCT02725008","briefTitle":"Trial of One Versus Two Doses of Dexamethasone for Pediatric Asthma Exacerbation","startDateStruct":{"date":"2015-11"},"conditions":["Asthma"],"count":99,"armGroups":[{"label":"Control","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Dexamethasone"]},{"label":"Investigational","type":"EXPERIMENTAL","interventionNames":["Drug: Dexamethasone","Drug: placebo"]}],"interventions":[{"name":"Dexamethasone","otherNames":["decadron"]},{"name":"placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* History of asthma defined as at least two (2) prior episodes of respiratory illness characterized by wheezing treated with inhaled beta agonists\n\nExclusion Criteria:\n\n* pregnancy\n* severe chronic cardiac, respiratory, neurological or neuromuscular disease\n* complete resolution of symptoms after one treatment of beta agonists\n* severe asthma symptoms as defined by a Pulmonary Index Score of 12 or greater","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Months","maximumAge":"20 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Treatment Failure","description":"number of patients who experience any of the following outcomes - unplanned hospital admission for asthma symptoms, unplanned ED visit for asthma symptoms, unplanned urgent care visit for asthma symptoms, unplanned primary care physician visit for asthma symptoms, or prescription of a course of steroids","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Symptom Severity From Day 1 to Day 5","description":"Severity of asthma symptoms as reported by the Patient Self Assessment Score. Patients assessed severity of asthma symptoms in 4 categories (wheezing, coughing, activity and sleep) once per day during the 5 days between study enrollment and follow-up. Score range is 0 - 12 with 0 being mildest symptoms and 12 being most severe symptoms. Reported as change in score between enrollment (day 1) and follow-up (day 5).","paramType":"MEDIAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4","spread":"3.39"},{"groupId":"OG001","value":"-4","spread":"3.29"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":46},"commonTop":["vomiting"]}}}